(NASDAQ: BLFS) Biolife Solutions's forecast annual revenue growth rate of -5.4% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.89%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.56%.
Biolife Solutions's revenue in 2025 is $123,359,000.On average, 4 Wall Street analysts forecast BLFS's revenue for 2025 to be $4,439,488,316, with the lowest BLFS revenue forecast at $4,257,418,501, and the highest BLFS revenue forecast at $4,710,157,710.
In 2026, BLFS is forecast to generate $5,121,148,426 in revenue, with the lowest revenue forecast at $4,986,625,505 and the highest revenue forecast at $5,255,671,346.